Next-generation sequencing for DLBCL patients with early failure after frontline R-CHOP chemo-immunotherapy

BackgroundEarly failure less than 12 months (POD12) of frontline R-CHOP chemo-immunotherapy in very poor outcomes and requires alternative therapy in patients with Diffuse large B-cell lymphoma (DLBCL).AimWe aim to evaluate the association of gene alterations and clinical factors with POD12.MethodsT...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Liu Shi, Xiaohua Liu, Jing Wang, Yong Su, Xiaochang Gong, Di Deng
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Frontiers Media S.A. 2026-02-01
Ráidu:	Frontiers in Oncology
Fáttát:	diffuse large B-cell lymphoma DLBCL early failure interim treatment responses next-generation sequencing
Liŋkkat:	https://www.frontiersin.org/articles/10.3389/fonc.2026.1682952/full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!